Purchase Order HHSN268201700211A

The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $121,347 firm fixed price purchase order to Cyagen Biomodels LLC of Santa Clara, California. The contract is for the generation of conditional knock-in and knock-out mouse models to support the agency's research focusing on the development of the mammalian hematopoietic system and study of signal transduction molecules and pathways that regulate T...

This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a part of the National Institutes of Health (NIH), to Gempharmatech LLC, a biotechnology company that specializes in developing humanized animal models. The contract is for the provision of a conditional knock-out mouse line to support NICHD's research. The contract has a ceiling value of $17,225 and a period of performance ending on August 31, 2022. Gempharmatech LLC has...

This is a firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the development of a conditional knockout mouse line to support NICHD's research. The total ceiling value of the contract is $14,380.00 with a completion date of January 5, 2024. There is no set-aside...

Kamtek Inc. has been awarded a $24,510 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute to provide transgenic mouse line creation and cryopreservation services for one year. Under this contract, Kamtek will create and cryopreserve transgenic mouse lines for future use in support of NHGRI's research efforts. The work will be performed by Kamtek in Frederick, Maryland and no subcontractors were identified. This purchase order draws...

This federal contract award to Ozgene Pty Ltd, an Australian company, provides genetically modified mice and related services to support biomedical research for the National Institutes of Health (NIH). The $7,286 firm fixed-price contract, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), is for the delivery of "Live Animals, Not Raised for Food" and has an ultimate completion date of April 28, 2010. Ozgene, as the prime contractor, provides gene targeting...

The National Institute of Child Health and Human Development (NICHD) awarded a $48,455 firm fixed-price purchase order to Cyagen US Inc., a biotechnology company based in Santa Clara, CA, to provide gene targeting services. The award is for the generation of conditional knockout and knockin mouse models to support NICHD's research on T cell receptor signaling and the development of the mammalian hematopoietic system. This award was made without a set-aside designation and has an ultimate...

This is a definitive contract awarded by the National Institutes of Health (NIH) to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $38,945,214.78, is for the provision of gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice to support research into various diseases and disorders, such as hemoglobin disorders, red blood cell development,...

The National Institutes of Health's National Institute of Child Health and Human Development awarded a $38,320 purchase order to Ozgene PTY LTD of Australia to generate a conditional knock-in mouse model of osteogenesis imperfecta. Under this firm fixed-price contract, Ozgene will deliver the genetically engineered mouse model to support research into this inherited disorder of connective tissue characterized by bone fragility and low bone mass. The one-year contract was awarded utilizing the...

This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $57,600 firm-fixed-price contract was for the generation of conditional gene knockout and knockin mouse models to support biomedical research. Ozgene, as the prime contractor, will provide gene targeting vector design and creation, mouse...

This federal contract award to Ozgene PTY LTD, an Australian company, is for the provision of gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice in support of biomedical research. The $70,800.00 firm fixed-price contract was awarded on June 2, 2011 by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The work supports research...